Non HDL-Cholesterol/HDL-Cholesterol Is a Better Predictor of Future Development of Metabolic Syndrome Than Apolipoprotein B/Apolipo protein A1

被引：0
|
作者：
Bae, Ji Cheol
Jin, Sang-Man
Kim, Jae Hyeon
Hur, Kyu Yeon
Lee, Myung-Shik
Lee, Moon Kyu
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1412-P
引用
收藏
页码：A368 / A368
页数：1
相关论文
共 50 条
  • [31] 11β-HSD type 1 is responsible for low plasma hdl-cholesterol and abdominal obesity in metabolic syndrome patients
    Atalar, F.
    Vural, B.
    Ciftci, C.
    Demirkan, A.
    Susleyici-Duman, B.
    Cagatay, P.
    Gunay, D.
    Sagbas, E.
    Akpinar, B.
    Ozbek, U.
    Buyukdevrim, A. S.
    FEBS JOURNAL, 2006, 273 : 203 - 203
  • [32] Novel Human Variants Of SR-B1 Impact HDL-cholesterol Clearance
    Powers, Hayley
    Sahoo, Daisy
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43
  • [33] Apolipoprotein B/HDL-cholesterol ratio (ApoB/HDL) is the best lipoprotein indicator of prevalent CHD in overweight and obese NHANES III participants
    Hsia, SH
    Pan, D
    DIABETES, 2004, 53 : A230 - A230
  • [34] LXR Driven Induction of HDL-Cholesterol is Independent of Intestinal Cholesterol Absorption and ABCA1 Protein Expression
    Kannisto, Kristina
    Gafvels, Mats
    Jiang, Zhao-Yan
    Slatis, Katharina
    Hu, Xiaoli
    Jorns, Carl
    Steffensen, Knut R.
    Eggertsen, Gosta
    LIPIDS, 2014, 49 (01) : 71 - 83
  • [35] ACCURACY OF HDL-CHOLESTEROL AND HDL-APOLIPOPROTEIN-A-I DETERMINATIONS AFTER PHOSPHOTUNGSTATE-MGCL2-PRECIPITATION OF APOLIPOPROTEIN-B-CONTAINING LIPOPROTEINS
    ASSMANN, G
    SCHRIEWER, H
    FUNKE, H
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1981, 19 (05): : 273 - 278
  • [36] Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level
    Paavola, Timo
    Kuusisto, Sanna
    Jauhiainen, Matti
    Kakko, Sakari
    Kangas-Kontio, Tiia
    Metso, Jari
    Soininen, Pasi
    Ala-Korpela, Mika
    Bloigu, Risto
    Hannuksela, Minna L.
    Savolainen, Markku J.
    Salonurmi, Tuire
    PLOS ONE, 2017, 12 (02):
  • [37] Improvement of HDL-cholesterol functional properties in patients with Metabolic Syndrome after a short period of exercise training
    Casella-Filho, A.
    Casella, C. B.
    Silva, V. M.
    Nascimento, B. C. G.
    Vinagre, C. G.
    Trombetta, I. C.
    Negrao, C. E.
    Maranhao, R. C.
    Daluz, P. L.
    Chagas, A. C. P.
    EUROPEAN HEART JOURNAL, 2007, 28 : 706 - 706
  • [38] The significance of HDL-cholesterol levels (used for cardiovascular risk stratification in essential hypertension) for metabolic syndrome detection
    Tsakiris, A
    Doumas, M
    Nearhou, N
    Nikolaou, V
    Kouremenou, C
    Skoufas, P
    JOURNAL OF HYPERTENSION, 2004, 22 : S228 - S228
  • [39] Peripheral polyneuropathy in severely obese patients with metabolic syndrome but without diabetes: Association with low HDL-cholesterol
    Nienov, Otto Henrique
    Matte, Luciana
    Dias, Lisiane Stefani
    Schmid, Helena
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (04): : 324 - 331
  • [40] ApoB/ApoA1 ratio and non-HDL-cholesterol/HDL-cholesterol ratio are associated to metabolic syndrome in patients with type 2 diabetes mellitus subjects and to ischemic cardiomyopathy in diabetic women
    Lizet Reynoso-Villalpando, Gabriela
    Sevillano-Collantes, Cristina
    Valle, Yeminia
    Moreno-Ruiz, Inmaculada
    Ramon Padilla-Gutierrez, Jorge
    Javier del Canizo-Gomez, Francisco
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2019, 66 (08): : 502 - 511
12345